Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMIG.L Regulatory News (MIG)

  • There is currently no data for MIG

Interim Management Statement

9 Feb 2016 17:02

RNS Number : 5771O
Mobeus Income & Growth 2 VCT PLC
09 February 2016
 

Mobeus Income & Growth 2 VCT plc

(the "Company")

 

INTERIM MANAGEMENT STATEMENT

For the quarter ended 31 December 2015

 

Mobeus Income & Growth 2 VCT plc presents an Interim Management Statement for the quarter ended 31 December 2015. The statement also includes relevant financial information between the end of the quarter and the date of this statement.

 

NET ASSET VALUE AND TOTAL RETURN PER SHARE

 

 

At 31 December 2015

At 30 September 2015

 

Net assets attributable to shareholders

ÂŁ44,749,017

ÂŁ43,980,781

Shares in issue

36,218,463

36,218,463

Net asset value (NAV) per share

123.55p

121.43p

Cumulative dividends paid to date per share

42.00p

42.00p

Total return per share since inception (NAV basis)

165.55p

163.43p

 

DIVIDENDS

 

No dividends were paid during the quarter.

 

The Board has today declared an interim dividend of 5.00 pence per share for the year ending 31 March 2016, which will be paid on 18 March 2016 to shareholders on the share register on 19 February 2016. This dividend fulfils the Company's target of paying a dividend in respect of each financial year of not less than 5.00 pence per share, as stated in the Annual Report and Accounts for the year ended 31 March 2015.

 

SHARE BUY-BACKS

 

There were no share buy-backs during the quarter.

 

INVESTMENT ACTIVITY

 

New Investments

 

On 2 October 2015, amounts held in existing companies preparing to trade, Knighton Management Limited (£0.89 million) and Tovey Management Limited (£0.85 million), were used to invest in Access IS Limited, a leading provider of data capture and scanning hardware. A further non-qualifying loan of £0.22 million was made to Access IS Limited.

 

A follow-on loan investment was also made into Racoon International of ÂŁ0.05 million, on 7 October 2015.

 

Realisations

 

On 2 December 2015, the Company realised its investment in Tessella Holdings Limited.

 

The Company received £2.10 million from the sale and realised a gain over cost of £1.39 million. As part of the transaction, the Company has retained a small investment in Preservica, a data archiving business previously held within Tessella. Total cash proceeds received over the life of this investment are £2.55 million and represent a multiple of 2.8 times the original cost of this investment of £0.91 million.

 

During January 2016, a total of ÂŁ0.17 million was received as deferred consideration from previous disposals of Monsal Holdings, Focus Pharma Holdings, Youngman Group and ATG Media Holdings.

 

Loan Stock Repayments

 

A total of ÂŁ0.23 million was received in loan stock repayments and premiums during the quarter to 31 December 2015, from Jablite, Leap New Co (Ward Thomas), and Fullfield (Motorclean).

 

After the quarter end, a further ÂŁ0.66 million in loan stock repayments and premiums was received from Leap New Co (Ward Thomas) and Fullfield (Motorclean).

REGULATORY DEVELOPMENTS

 

In the Half-Yearly Report to shareholders dated 26 November 2015, the Board informed shareholders of its intended response to the new legislation contained in the UK Finance Act 2015, which had become law on 18 November 2015. In summary, the new rules are designed to ensure that VCT investment is used only for growth and development purposes. Investments by VCTs to finance the acquisitions of businesses, such as MBO investments, are no longer permitted. The Board stated that it would draft a revised Investment Policy which it would invite shareholders to approve at or before the next annual general meeting.

 

Since the Half-Yearly Report, the Board has continued to work with the Investment Adviser and other professional advisers to understand the full implications of the new rules for the Investment Policy. At this juncture, the Board sees no reason to amend its response, as outlined above and more fully in the Half-Yearly Report. Alongside this process, the Investment Adviser is focusing upon investment opportunities that comply with the new legislation.

 

 

 

Please note that all of the information above is unaudited.

 

Other than as described above, there were no material events during the quarter and to the date of this announcement.

 

 

For further information, please contact:

Jonathan McGuire, for Mobeus Equity Partners LLP, Company Secretary: 020 7024 7600

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSQKLFBQLFEBBK
Date   Source Headline
12th Dec 201912:40 pmRNSTransaction in Own Shares
28th Nov 201910:15 amRNSHalf-Year Report for the six months ended 30/09/19
20th Nov 20191:00 pmRNSHalf-year Report
5th Nov 20194:00 pmRNSReduction of Capital
25th Oct 20194:00 pmRNSPublication of a Prospectus
11th Oct 20193:00 pmRNSResult of Meeting
1st Oct 201910:00 amRNSTotal Voting Rights
27th Sep 201912:00 pmRNSTransaction in Own Shares
11th Sep 201912:41 pmRNSResult of AGM
10th Sep 20195:00 pmRNSFundraising Update, Circular and General Meetings
10th Sep 20195:00 pmRNSNotice of GM
10th Sep 20195:00 pmRNSNotice of GM
10th Sep 20195:00 pmRNSNotice of GM
8th Aug 201910:59 amRNSInterim Management Statement to 30 June 2019
29th Jul 201911:00 amRNSShare buyback policy objective
29th Jul 20197:00 amRNSIntention to launch offers for subscription
2nd Jul 20199:16 amRNSRealisation of investment
1st Jul 201911:43 amRNSTransaction in Own Shares
25th Jun 20191:04 pmRNSAnnual Financial Report
24th Jun 20198:52 amRNSTransaction in Own Shares
19th Jun 20191:49 pmRNSAnnual Results for the year ended 31 March 2019
4th Mar 20199:18 amRNSTransaction in Own Shares
13th Feb 20191:55 pmRNSInterim Management Statement - 3rd Quarter
17th Dec 20189:43 amRNSTransaction in Own Shares
21st Nov 201810:27 amRNSHalf-year Report
12th Sep 20182:18 pmRNSAGM Statement
11th Sep 20183:18 pmRNSInterim Management Statement to 30 June 2018
14th Aug 20183:58 pmRNSNet Asset Value(s)
26th Jun 20182:53 pmRNSNSM Filing
22nd Jun 20183:04 pmRNSAnnual Financial Report
14th Jun 20189:00 amRNSDirectorate Change
27th Mar 20184:53 pmRNSTransaction in Own Shares
13th Mar 20184:32 pmRNSIssue of Equity
9th Feb 201810:35 amRNSInterim Management Statement
25th Jan 20189:34 amRNSIssue of Equity
5th Jan 201812:37 pmRNSRealisation of Investment in Gro-Group
5th Jan 201811:22 amRNSTotal Voting Rights
21st Dec 20179:20 amRNSTransaction in Own Shares
20th Dec 20171:54 pmRNSPublication of Suppl.Prospcts
12th Dec 20172:21 pmRNSHalf-year Report
30th Nov 20179:15 amRNSJoint Announcement - Fundraising Update
30th Nov 20179:15 amRNSJoint Announcement - Fundraising Update
30th Nov 20179:14 amRNSJoint Announcement - Fundraising Update
30th Nov 20179:11 amRNSJoint Announcement - Fundraising Update
22nd Nov 20179:29 amRNSIssue of Equity
21st Nov 201710:01 amRNSIssue of Equity
10th Nov 201710:25 amRNSIssue of Equity
1st Nov 201712:43 pmRNSIncrease in Offer size. Expiry of early incentive.
20th Oct 20172:22 pmRNSIssue of Equity
13th Oct 201711:23 amRNSOver-Allotment Facility

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.